Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 5 (2008), Issue 12 (December)

1. Robotic versus open radical hysterectomy: a comparative study at a single institution.
   Gynecol Oncol, 111(3): 425-30. [Abstract] [Full-text]
2. XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.
   Gynecol Oncol, 111(3): 509-15. [Abstract] [Full-text]
3. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
   Gynecol Oncol, 111(3): 438-43. [Abstract] [Full-text]
4. Health status and adaptation among long-term cervical cancer survivors.
   Gynecol Oncol, 111(3): 449-54. [Abstract] [Full-text]
5. Abdominal radical trachelectomy for invasive cervical cancer: a case series and literature review.
   Gynecol Oncol, 111(3): 555-60. [Abstract] [Full-text]
6. Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.
   Gynecol Oncol, 111(3): 444-8. [Abstract] [Full-text]
7. Embryonal rhabdomyosarcoma of the uterine cervix in a 41-year-old woman treated with radical hysterectomy and adjuvant chemotherapy.
   Gynecol Oncol, 111(3): 561-3. [Abstract] [Full-text]
8. Robot-assisted abdominal laparoscopic radical trachelectomy.
   Gynecol Oncol, 111(3): 564-7. [Abstract] [Full-text]
9. AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.
   Expert Rev Vaccines, 7(10): 1465-73. [Abstract] [Full-text]
10. Pediatricians are more supportive of the human papillomavirus vaccine than the general public.
    South Med J, 101(12): 1216-21. [Abstract] [Full-text]
11. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
    Int J Cancer, 124(1): 188-93. [Abstract] [Full-text]
12. Cervical screening in Canadian First Nation Cree women.
    J Transcult Nurs, 20(1): 83-92. [Abstract] [Full-text]
13. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.
    J Clin Oncol, 26(35): 5802-12. [Abstract] [Full-text]
14. Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.
    Cancer Res, 68(24): 10333-40. [Abstract] [Full-text]
15. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin.
    Int J Cancer, 124(2): 287-97. [Abstract] [Full-text]
16. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer.
    Int J Cancer, 124(2): 381-6. [Abstract] [Full-text]
17. How many cervical cancers are prevented by treatment of screen-detected disease in young women?
    Int J Cancer, 124(2): 461-4. [Abstract] [Full-text]
18. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.
    Eur J Cancer Prev, 18(1): 56-61. [Abstract] [Full-text]
19. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype.
    Int J Cancer, 124(4): 778-82. [Abstract] [Full-text]
20. HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness.
    Int J Cancer, 124(4): 970-8. [Abstract] [Full-text]
21. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.
    Int J Cancer, 124(4): 964-9. [Abstract] [Full-text]
22. Hematologic malignancies of the female genital tract diagnosed on liquid-based Pap test: Cytomorphologic features and review of differential diagnoses.
    Diagn Cytopathol, 37(1): 61-7. [Abstract] [Full-text]
23. Human papillomavirus vaccine acceptability among young adult men.
    Sex Transm Dis, 36(1): 58-62. [Abstract] [Full-text]
24. Clear cell adenocarcinoma of the uterine cervix arising from a background of cervical endometriosis.
    Br J Radiol, 82(973): e20-2. [Abstract] [Full-text]
25. Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study.
    Gynecol Oncol, 112(1): 95-103. [Abstract] [Full-text]
26. A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study.
    Gynecol Oncol, 112(1): 78-84. [Abstract] [Full-text]
27. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    Gynecol Oncol, 112(1): 119-25. [Abstract] [Full-text]
28. HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression.
    Gynecol Oncol, 112(1): 114-8. [Abstract] [Full-text]
29. Proteomic identification of differentially-expressed proteins in squamous cervical cancer.
    Gynecol Oncol, 112(1): 248-56. [Abstract] [Full-text]
30. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gynecol Oncol, 112(1): 85-9. [Abstract] [Full-text]
31. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
    Gynecol Oncol, 112(1): 241-7. [Abstract] [Full-text]
32. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
    Gynecol Oncol, 112(1): 235-40. [Abstract] [Full-text]
33. Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes.
    Gynecol Oncol, 112(1): 73-7. [Abstract] [Full-text]
34. Post radical hysterectomy urinary incontinence: a prospective study of transurethral bulking agents injection.
    Gynecol Oncol, 112(1): 90-4. [Abstract] [Full-text]
35. Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.
    Gynecol Oncol, 112(1): 110-3. [Abstract] [Full-text]
36. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
    Gynecol Oncol, 112(1): 104-9. [Abstract] [Full-text]
37. Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.
    Int J Radiat Oncol Biol Phys, 73(1): 242-50. [Abstract] [Full-text]
38. Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence.
    Eur J Cancer, 45(1): 107-18. [Abstract] [Full-text]
39. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.
    Appl Immunohistochem Mol Morphol, 17(1): 8-11. [Abstract] [Full-text]
40. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: analysis of surgical and oncological outcome.
    Eur J Surg Oncol, 35(1): 98-103. [Abstract] [Full-text]
41. Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma.
    Int J Radiat Oncol Biol Phys, 73(1): 251-8. [Abstract] [Full-text]
42. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer.
    Int J Radiat Oncol Biol Phys, 73(1): 235-41. [Abstract] [Full-text]
43. A method to estimate mortality trends when death certificates are imprecisely coded: an application to cervical cancer in Italy.
    Int J Cancer, 124(5): 1200-5. [Abstract] [Full-text]
44. Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: an explanation for the molecular role of tobacco smoking in cervical carcinogenesis?
    Int J Cancer, 124(5): 1090-6. [Abstract] [Full-text]
45. Inhibition of Akt signaling by SN-38 induces apoptosis in cervical cancer.
    Cancer Lett, 274(1): 47-53. [Abstract] [Full-text]

© 2004-2010 Cervical Cancer Research Today. All Rights Reserved.